Microglia Function Professors and Supervisors | ApplySharif

Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 721-735 of 961 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Masha Prager-KhoutorskyView profile

Associate Professor

McGill UniversityCanada

Masha Prager-Khoutorsky is an Associate Professor in the Department of Physiology at McGill University's Faculty of Medicine. She leads a research group focused on neurophysiological mechanisms underlying brain regulation of bodily functions, particularly in the hypothalamus. Her work examines how hypothalamic areas communicate with peripheral systems to maintain homeostasis in metabolism, fluid balance, and cardiovascular function. Key research themes include sodium detection mechanisms in hypertension, blood-brain barrier regulation by non-neuronal cells, and circadian rhythm impacts on metabolic disorders. Her research employs advanced techniques such as patch-clamp electrophysiology, superresolution imaging, and hemodynamic measurements. Current investigations target cellular stress pathways in pain modulation, microglial-neuronal interactions, and the role of circadian nuclei in blood glucose regulation. The lab actively seeks graduate and undergraduate researchers. Publications span topics from neuroendocrine signaling to translational control mechanisms in neurological disorders. Her work has advanced understanding of mechanosensory transduction in osmosensory neurons and the structural plasticity of cytoskeletal networks in magnocellular neurons.

Official University Profile

Damian HolsingerView profile

Senior Lecturer

University of SydneyAustralia

Dr Damian Holsinger is a Senior Lecturer in Neuroscience at the University of Sydney's School of Medical Sciences and Head of the Laboratory of Molecular Neuroscience and Dementia. His research focuses on Alzheimer's disease mechanisms, neurodegenerative disorders, and innovative treatments like fecal microbiota transplantation. He is also a member of the University of Sydney Nano Institute and serves on the Alzheimer's Association USA IRGP Council. Research interests include molecular mechanisms underlying Alzheimer's, neuroinflammation, and non-pharmacological interventions. He has published over 100 peer-reviewed articles and edited multiple journal special issues. Notable awards include the SUPRA Supervisor of the Year 2022 and NIH grants for BACE1 research. Key projects involve microbiota transplantation, nanoscaffolds for nerve regeneration, and electrical stimulation therapies. His work bridges clinical translation and basic science, with a focus on early-stage drug discovery and systems biology approaches. Teaching responsibilities include Neuroanatomy, Neuropathology, and Molecular Neuroscience courses (BIOS1166, BIOS1167, BIOS2166, BIOS3166). He advises PhD students on Alzheimer's-related projects and collaborates on grants exploring microglia-synapse interactions and glioma treatment strategies. Media engagements include ABC News commentary on neurodegenerative stress responses and radio discussions on pandemic-related mental health. His lab actively investigates biomarkers linking blood and brain signatures in Alzheimer's, leveraging interdisciplinary approaches.

Official University Profile

Victoria Gomez MurciaView profile

Assistant Professor

University of MurciaSpain

Victoria Gomez Murcia is an Assistant Professor at the Department of Pharmacology, Faculty of Veterinary Medicine, University of Murcia. Her research focuses on neuropharmacology, addictive disorders, and Alzheimer’s disease mechanisms. She holds a PhD from the University of Murcia (2016) with a thesis on opioid dependence and drug formulation. Her work combines behavioral pharmacology with molecular mechanisms, particularly targeting dopamine and adenosine receptors in addiction and neurodegenerative contexts. Research interests include opioid withdrawal-induced memories, synaptic plasticity in addiction, and the role of adenosine receptors in Alzheimer’s pathology. She also explores drug delivery systems for prolonged analgesia. Recent studies highlight the therapeutic potential of dopamine D3 receptor antagonism in extinguishing drug-seeking behaviors and the exacerbating role of A2A receptors in Alzheimer’s synaptic loss. Her publications reflect a multidisciplinary approach, integrating animal models (rat/mice), molecular techniques (histone modification analysis, pathway signaling), and translational pharmacology. While no explicit awards are listed, her active research portfolio suggests competitive grant opportunities in neuroscience and pharmacology. Victoria collaborates with interdisciplinary teams in neuropharmacology and veterinary medicine, contributing to both basic science and educational innovations like flipped-classroom methodologies in pharmacy training.

Official University Profile

Jelle HendrixView profile

Senior Lecturer

Hasselt UniversityBelgium

Prof. dr. Jelle Hendrix is a Senior Lecturer at Hasselt University's Faculty of Medicine and Life Sciences, Department of Neuroscience. He leads the Dynamic Bioimaging Lab and manages the Advanced Optical Microscopy Center core facility. His research focuses on advanced optical imaging techniques to study molecular mechanisms in neuroscience and structural biology, particularly protein dynamics and biomolecular interactions. He serves as Deputy Ombudsman and sits on the Examination Board for the Bachelor of Medicine program. Research interests span multiple biophysical domains: Single-molecule fluorescence microscopy for structural biology Protein conformation dynamics in neurodegeneration Biomolecular condensate characterization G-protein coupled receptor mechanisms Advanced microscopy method development Microfluidic approaches for protein interaction studies His publication portfolio reveals strong emphasis on single-molecule imaging techniques applied to membrane proteins, neurodegenerative mechanisms, and receptor dynamics. Recent work demonstrates growing interest in integrating computational approaches with experimental biophysics to study protein phase separation and its role in disease pathologies. Current research projects include: Flanders BioImaging (2023-2026): Integrated biological imaging services MULTISCALE Optical Imaging Core (2022-2026): Nanoscale to centimeter microscopy infrastructure Structuromics@UHasselt (2025-2030): Biomolecular assembly platform INSITE (2024-2027): Liquid protein condensate framework He currently advises 9 PhD students working on projects ranging from tauopathy mechanisms to real-time structural biology of membrane proteins. His Dynamic Bioimaging Lab develops novel methodologies for studying biological systems at unprecedented spatiotemporal resolutions.

Official University Profile

Antoine LouveauView profile

Assistant Professor

Kent State UniversityUnited States

Dr. Antoine Louveau is an Assistant Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University (CCLCM-CWRU), where he serves as Principal Investigator of the Louveau Laboratory within the Lerner Research Institute. His research focuses on the critical interface between the brain and immune system, specifically investigating the role of meningeal lymphatic vessels in normal and pathological brain function. Dr. Louveau's research interests span multiple areas of neuroimmunology and neuroscience: Meningeal lymphatic system and its role in CNS immunity Neuroimmune interactions in neurological disorders Alzheimer's disease and multiple sclerosis pathogenesis Brain barriers and immune cell trafficking Neuroinflammation and therapeutic interventions His laboratory has made significant contributions to understanding how meningeal lymphatic vessels regulate CNS drainage and immune responses. Dr. Louveau's research has revealed connections between meningeal lymphatic dysfunction and neurological disorders including Alzheimer's disease and multiple sclerosis. His team has demonstrated how meningeal lymphatics impact microglial responses and the efficacy of immunotherapies for neurodegenerative conditions. Analysis of his publication record shows consistent focus on meningeal lymphatic structure, function, and therapeutic potential across neurological conditions. Dr. Louveau has received recognition as a "CIMER Trained Mentor," indicating completion of specialized mentorship training aimed at advancing mentoring relationships and promoting cultural change in research. As a principal investigator, Dr. Louveau mentors several trainees including postdoctoral fellows, graduate students, and undergraduate research students. His laboratory collaborates extensively with other researchers at Cleveland Clinic and beyond to investigate the complex relationships between the nervous and immune systems. The Louveau Laboratory is part of the Lerner Research Institute at Cleveland Clinic, a premier biomedical research institution that provides state-of-the-art facilities and resources for cutting-edge neuroscience research.

Official University Profile

Erin Reed-GeaghanView profile

Assistant Professor

Northeast Ohio Medical UniversityUnited States

Erin Reed-Geaghan, Ph.D., is an Assistant Professor of Pharmaceutical Sciences and a member of the Graduate Faculty II at the College of Graduate Studies, Northeast Ohio Medical University (NEOMED). Her research focuses on neuroinflammatory mechanisms in Alzheimer’s disease, particularly the role of microglia and inflammatory mediators. She holds a Ph.D. in Neuroscience from Case Western Reserve University (2010) and a B.A. in Biology from Colby College (2003). Education: Ph.D. in Neuroscience, Case Western Reserve University, 2010 B.A. in Biology, Colby College, 2003 Her research interests include microglial function, neuroinflammation, and the molecular pathways driving Alzheimer’s pathology. She has received prestigious awards such as the National Research Service Award (both pre- and post-doctoral) and a BrightFocus Foundation grant. Dr. Reed-Geaghan also teaches immunology and biotechnology courses and was honored with the 2021 Innovation in Teaching Award in Pharmacy. Her publications explore CD14’s role in Alzheimer’s pathology, microglial depletion effects on amyloid plaques, and the origins of myeloid cells in neurodegenerative diseases. She collaborates with institutions like the Clinical and Translational Research Institute and maintains an active lab at NEOMED.

Official University Profile

Daniel WehnerView profile

Researcher

Max Planck Institute for the Science of LightGermany

Daniel Wehner is a Researcher and head of the Neuroregeneration research group at the Max Planck Institute for the Science of Light and Max-Planck-Zentrum für Physik und Medizin in Erlangen, Germany. His work focuses on understanding spinal cord regeneration in zebrafish, contrasting their regenerative capacity with mammals' inability to recover from spinal cord injuries. B.Sc. in Bio- and Nanotechnologies, South Westphalia University of Applied Sciences Intercalated B.Sc. in Medical Biotechnology, Abertay University Ph.D. in Developmental Biology, Technische Universität Dresden/Ulm University His research investigates the extracellular matrix (ECM) environment post-injury in zebrafish, using advanced optical imaging techniques like Brillouin microscopy and femtosecond laser systems to compare regeneration-permissive vs. scar-forming environments. Recent work highlights the role of microglia in tissue contraction and the inhibition of CNS regeneration by small leucine-rich proteoglycans . Dr. Wehner's group develops humanized zebrafish models for therapeutic spinal cord repair strategies. He was awarded the ISRB Rising Star Award 2024 for pioneering contributions to regenerative biology. Contact: daniel.wehner@mpl.mpg.de 2024: ISRB Rising Star Award

Official University Profile

Constanza Garcia KellerView profile

Assistant Professor

Medical College of WisconsinUnited States

Dr. Constanza Garcia Keller is an Assistant Professor in the Department of Pharmacology and Toxicology at the Medical College of Wisconsin (MCW), joining in July 2022. Her academic journey includes a BS in Chemical Sciences (2007) and a PhD in Pharmacology (2014) from the National University of Córdoba, Argentina, followed by postdoctoral training and a research assistant professorship in Dr. Kalivas’ laboratory at the Medical University of South Carolina. Her research focuses on the neurobiological mechanisms linking stress, trauma, and addiction, particularly examining synaptic plasticity, extracellular matrix interactions, and neuroimmune-endocrine pathways. Educational Background Bachelor of Science in Chemical Sciences, National University of Córdoba (2007) PhD in Pharmacology, National University of Córdoba (2014) Postdoctoral Training in Neuroscience, Medical University of South Carolina (2014–2019) Research Interests Dr. Garcia Keller’s lab investigates how acute stress and traumatic events increase vulnerability to substance use disorders (SUDs), with a focus on the pentapartite synapse (neurons, astrocytes, microglia, extracellular matrix). Key projects include: Neurocircuitry and cell-type specificity in stress/addiction Role of ECM signaling and microglia activation Development of oligonucleotide-based therapies targeting genes involved in SUDs Awards & Grants 2014: Best Argentinian Neuroscience Thesis Award 2022–2013: Multiple travel and fellowship awards from ACNP, ISN, and CONICET Labs & Collaborations Her lab uses rodent models to study stress-induced neuroplasticity and SUD comorbidity, with a focus on translational therapies targeting synaptic and glial mechanisms.

Official University Profile

Antje Kroner-MilschView profile

Associate Professor

Medical College of WisconsinUnited States

Dr. Antje Kroner-Milsch is an Associate Professor in the Department of Neurosurgery at the Medical College of Wisconsin. Her research focuses on modifying the inflammatory response after spinal cord injury, with a particular emphasis on macrophages and microglia. She holds an MD from Julius-Maximilians-University (2002) and a PhD in Neuroscience (2008), both from Wuerzburg, Germany. She completed postdoctoral training at McGill University (2009-2015) before joining MCW in 2015. Education: MD, Julius-Maximilians-University, Wuerzburg, Germany (2002) PhD in Neuroscience, Julius-Maximilians-University, Wuerzburg, Germany (2008) Postdoctoral Fellowships: Neurology at McGill University (2009-2014) and Julius-Maximilians-University (2008-2009) Research Associate, McGill University (2014-2015) Research Interests: Dr. Kroner-Milsch investigates the role of inflammation in spinal cord injury, particularly targeting macrophage behavior and ferroptosis. Her work aims to develop therapies that modulate inflammatory responses to improve outcomes. Techniques include flow cytometry, histology, and preclinical mouse models. Awards: Young Investigator Award in Multiple Sclerosis (2005, Wyeth) Advising & Grants: While specific grant details are not listed, her extensive publication record indicates sustained research activity. No students are explicitly named in the provided text. Labs/Teams: Her research is conducted within the Neuroscience Research Labs at the Medical College of Wisconsin, focusing on translational spinal cord injury therapies.

Official University Profile

Peter M. GraceView profile

Associate Professor

The University of Texas MD Anderson Cancer CenterUnited States

Peter M. Grace, Ph.D., is an Associate Professor and interim Department Chair in the Department of Symptom Research at The University of Texas MD Anderson Cancer Center. His research focuses on neuroimmune mechanisms underlying chronic pain, particularly neuropathic pain and opioid pharmacology. He investigates pathways such as Nrf2 antioxidant signaling, inflammasome activation, and immune-mediated pain modulation. His work bridges basic science and translational research, aiming to develop therapies targeting oxidative stress and neuroinflammation. Key research interests include the role of B cells and IgG in neuropathic pain, the impact of opioids on pain amplification, and the protective effects of exercise on nerve injury outcomes. He explores novel therapies like fumarates and HDAC inhibitors to mitigate pain and neurodegeneration. Grace’s interdisciplinary approach integrates immunology, neuroscience, and clinical pain management. His publications highlight advancements in understanding microglial activity in pain-related brain regions, TLR4 signaling in morphine tolerance, and the development of targeted drug delivery systems for oxidative stress disorders. Despite his extensive contributions, specific awards are not listed in the provided materials.

Official University Profile

Hongwei YuView profile

Professor

Medical College of WisconsinUnited States

Hongwei Yu, MD is a Professor in the Department of Anesthesiology at the Medical College of Wisconsin. His research focuses on developing recombinant adeno-associated viral (AAV) vectors to manipulate genes in the peripheral sensory nervous system for studying pain mechanisms and treating chronic pain. He leads efforts to create AAV vectors targeting sensory neurons, satellite glial cells, and microglia for therapeutic applications. Education: MD from Binzhou Medical College (China), MS from Shandong University Medical School (China), and postdoctoral training at the Medical University of South Carolina. Research emphasizes gene and molecular therapy for chronic pain, with a focus on sodium channels, Piezo1/2 ion channels, and T-type calcium channels. His lab pioneered SGC-specific AAV vectors (sgcAAV) and microglia-specific AAV (mgAAV) for glial cell targeting. Current projects include AAV-encoded interfering peptide aptamers (AAV-iPAs) for pain modulation and dual AAV strategies targeting neurons and glia. Publications span mechanosensitive ion channel roles in pain, AAV-based gene delivery systems, and translational models of neuropathic pain. His work bridges molecular mechanisms with clinical applications in pain management.

Official University Profile

Yuan PanView profile

Assistant Professor

The University of Texas MD Anderson Cancer CenterUnited States

Dr. Yuan Pan is an Assistant Professor at The University of Texas MD Anderson Cancer Center, holding dual appointments in the Department of Symptom Research (Division of Internal Medicine) and the Department of Neuro-Oncology (Division of Cancer Medicine). Her research bridges neuroscience and cancer biology, focusing on neuron-cancer interactions and neurofibromatosis type 1 (NF1)-related gliomas. She leads the Pan Lab, which investigates how neuronal activity, glial biology, and chemotherapy impact nervous system cancers, aiming to improve patient outcomes through novel therapeutic strategies. Dr. Pan trained with renowned scientists Drs. David Gutmann and Michelle Monje, contributing seminal work on NF1 mutations and optic glioma pathogenesis (Pan et al., Nature, 2021). Since establishing her independent lab in 2022, she has secured CPRIT Scholar funding and advanced studies on neuroimmune interactions, tumor microenvironment dynamics, and activity-dependent tumor initiation. Her work highlights the critical role of neural circuits in cancer progression. Key Awards: CPRIT Scholar in Cancer Research (2022) Research Themes: Neuronal-glial crosstalk, neurofibromatosis, tumor immunology, chemotherapy effects Labs/Teams: Pan Lab (MD Anderson Cancer Center) Her publications reveal a focus on low-grade glioma mechanisms, chemokine signaling, and systems biology approaches to identify tumor-specific networks. Clinical and translational efforts aim to translate these findings into improved diagnostics and therapies.

Official University Profile

Michael NicholsView profile

Professor

University of Missouri Saint LouisUnited States

Dr. Michael Nichols is a Professor and Director of the Biochemistry and Biotechnology Program at the University of Missouri–St. Louis (UMSL). He holds a B.S. from Lindenwood College and a Ph.D. from Purdue University. His postdoctoral training at the Mayo Clinic in Jacksonville, FL, focused on biophysical analysis of proteins. His research interests center on Alzheimer’s Disease, with a focus on amyloid-beta aggregation mechanisms, protein biophysics, cellular signaling, and inflammatory pathways. Key techniques include chromatography, light scattering, microscopy (atomic force, confocal), and cell culture studies. Dr. Nichols explores how amyloid-beta species interact with microglia and their role in neuroinflammation, with implications for therapeutic interventions. His research output spans over 30 peer-reviewed articles, emphasizing structural biology of amyloid proteins, inflammasome activation, and protein aggregation dynamics. Notable trends include investigations into protofibril conformation effects, microglial response modulation, and novel antibody development targeting amyloid species. No scientific awards or grants are explicitly listed in the provided text. Dr. Nichols advises students through his role in the Biochemistry and Biotechnology Program but no specific advisee names are provided.

Official University Profile

Imelda McGonnellView profile

Researcher

Royal Veterinary CollegeUnited Kingdom

Imelda McGonnell is a Reader in Comparative Medicine at the Royal Veterinary College's Department of Comparative Biomedical Sciences. Her research bridges human and animal disease models, focusing on developmental disorders and cancer through zebrafish and canine mammary tumor studies. Key Research Areas: Microbiome-neuronal development interactions Mechanisms of canine mammary tumourigenesis Signaling pathways in Tasmanian Devil Facial Tumour Disease Collaborations: University of Tasmania Southampton University She employs germ-free zebrafish models, traditional disease models, and in vitro techniques to investigate molecular disease mechanisms. Her work also explores mechanosensitivity in embryonic limb development and comparative models of Chiari-like malformation.

Official University Profile

Viviane TabarView profile

Professor

Memorial Sloan Kettering Cancer CenterUnited States

Viviane Tabar, MD, is a neurosurgeon-scientist and Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSKCC). Her clinical expertise includes surgical management of brain tumors, such as gliomas, meningiomas, and skull base tumors. She specializes in minimally invasive techniques, intraoperative imaging, and brain mapping to preserve critical neural functions. Dr. Tabar is also a leading researcher in stem cell biology, focusing on regenerative therapies for brain repair (e.g., Parkinson’s disease) and modeling brain tumors using human pluripotent stem cells. Her lab investigates glioma biology, tumor heterogeneity, and radiation-induced brain injury. Education and Training: MD from the American University of Beirut; residencies in General Surgery and Neurosurgery at Case Western Reserve University and University of Massachusetts; fellowship in Neurosurgical Oncology at MSKCC. Board-certified in Neurological Surgery. Research Highlights Her lab’s key projects include: Stem cell-derived grafts for radiation injury repair. Modeling pediatric gliomas (e.g., H3.3K27M mutations) using human embryonic stem cells. Developing clinical trials for stem cell therapies in Parkinson’s disease. Awards and Recognition Recipient of the American Brain Tumor Association Young Investigator Award (2016), Preuss Award (2010), and multiple Castle Connolly honors. Elected to the National Academy of Medicine. Lab Collaborations Collaborates with the Center for Stem Cell Biology and Gerstner Sloan Kettering Graduate School. Current lab members include postdoctoral fellows, research assistants, and a graduate student. Publications span stem cell therapies, glioma models, and clinical innovations, with a focus on translational research to bridge surgical practice and scientific discovery.

Official University Profile